Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Orica (ORI.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-03-30	16.10	15.50	Neutral
2022-05-12	16.40	16.70	Neutral
2022-08-03	17.20	17.00	Neutral
2022-11-04	14.16	18.00	Buy
2023-05-11	16.61	19.00	Buy
2023-09-19	15.88	18.80	Buy
2023-11-09	15.48	18.85	Buy
2023-12-20	16.21	19.00	Buy
2024-02-15	16.82	19.40	Buy
2024-02-21	16.85	19.50	Buy
2024-05-03	17.71	21.30	Buy
2024-09-25	18.02	21.15	Buy
2024-11-15	18.10	21.00	Buy
2025-03-12	16.68	22.00	Buy

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.